Publication:
Soru 19– Fibratların kardiyovasküler olaylara etkisi var mı?

Simple item page
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorUral, Dilek
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-10T00:05:49Z
dc.date.issued2017
dc.description.abstractHeart disease in men with low levels of high-density lipoproteincholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410–8 / Fenofibrat/simvastatin kombinasyonu ortalama 4.7 yıllık izlemde ölümcül olmayan ME, inme veya KV ölümleri hafifçe (%8; p=0.32) azalttı. Adl olan Tip 2DM hastalarında ölümcül olmayan ME, inme veya KV ölümler (%31; p=0.032) azaldı
dc.description.indexedbyTR Dizin
dc.description.issueSuppl. 1 (Özel Sayı)
dc.description.publisherscopeNational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume45
dc.identifier.eissn1308-4488
dc.identifier.issn1016-5169
dc.identifier.urihttps://hdl.handle.net/20.500.14288/16501
dc.keywordsDyslipidaemia
dc.keywordsCardiovascular risk
dc.keywordsInfarct / Dispilidemi
dc.keywordsKardiyovasküler risk
dc.keywordsEnfarktüs
dc.language.isotur
dc.publisherAves
dc.relation.ispartofArchives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi
dc.subjectCardiology
dc.subjectDyslipidemia / Kardiyoloji
dc.subjectDispilidemi
dc.titleSoru 19– Fibratların kardiyovasküler olaylara etkisi var mı?
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorUral, Dilek
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext